Division Underpinning rapid development of pharmaceutical countermeasures including vaccines, for new and emerging threats

The likelihood of new pathogens emerging in previously uninfected areas is increasing, capable of causing widespread disease, led by factors such as expanding travel, climate and other environmental change, and evolution of the pathogen/vector/reservoir relationship. The challenge is to enable the rapid development, production and licensing of vaccines for new and emerging diseases to protect the population of Europe and beyond.

The activity to be developed is the following:

• development of a process to accelerate production release of vaccines in case of emergency needs,

• strengthening network of clinical centres to support extensive vaccine development,

• developing broadly applicable platforms for vaccines.

  [Call for proposals for projects]